Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Launched by NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI) · Sep 3, 2016

Keywords

ClinConnect Summary

This clinical trial is studying a condition called propionic acidemia (PA), which is a metabolic disease that affects how the body breaks down food. People with PA can experience a variety of health issues, including problems with growth and learning, as well as heart and abdominal complications. The researchers aim to learn more about how PA develops and the genes that might play a role in it. The study is open to individuals who are at least 2 years old and have been diagnosed with PA, as well as some unaffected family members who can participate in certain assessments.

Participants in the study will visit a hospital for 3 to 5 days each year or every few years for a range of tests and evaluations. These might include blood and urine samples, medical history reviews, dietary assessments, and various health checks, such as ultrasounds and heart tests. Unaffected family members may have fewer visits, but they will still provide important information for the study. It’s important to know that pregnant participants can remain in the study, but certain procedures will be limited during their pregnancy. Overall, this research aims to gather valuable insights into PA, which could help improve care and treatment for those affected by this condition.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Patients 2 years of age or older, of any gender and ethnicity, with propionic acidemia are eligible to enroll in this protocol. Patients diagnosis will be confirmed based on biochemical and/or molecular and enzymatic testing. Participants of any gender and ethnicity over 1 month of age are eligible to enroll remotely for collection of outside records and natural history data. They will be eligible to enroll in the full study for in-person evaluation at 2 years of age.
• • Unaffected family members over 1 month of age, of any ethnicity or race, may be included in the study as household controls for microbiome studies and/or for genetic analysis. Studies in unaffected family members may include collection of medical and family history; if necessary completion of physical examination; drawing of blood for research purposes include testing of DNA; collection of stool samples for microbiome studies; collection of dietary history using pen- and- paper or electronic food diary and questionnaires; collection of saliva for metabolite and DNA analysis. In some unaffected family members without a known familial cause of propionic acidemia, exome sequencing or genome sequencing could be performed. Unaffected family members will not receive direct benefit from taking part in the study.
• • If a participant becomes pregnant while on study, the participant can remain on study. The only way to learn more about the critical biological differences in those who affected with propionic acidemia who are pregnant is to continue to follow pregnant women on study.
• • However, no tests or procedures that are greater then minimal risk will be performed. Affected subjects who are pregnant may undergo procedures as part of their clinical care, including blood draws, genetic studies, and consultations, according to the clinical judgement of the clinical team. However, pregnant participants will be excluded from procedures such as organ tissue collection, stable isotope studies, GFR testing, and brain or cardiac MRI until the pregnancy is concluded.
• • Healthy volunteers may be eligible to participate in the study if they are between 12 40 years of age, must meet specific BMI criteria (similar to affected individuals studied).
• • Patients with propionic acidemia over 1 month of age, of any gender and ethnicity, undergoing a transplantation surgery at Children s Hospital of Pittsburgh, are eligible to participate in the tissue collection arm of the study.
• EXCLUSION CRITERIA:
• • The PI/AI may decline to enroll a patient because of poor metabolic control, lack of a primary metabolic/genetics physician, and intercurrent infection are exclusion criteria for this protocol, the likelihood that an acutely ill or poorly controlled patient will enroll will be minimized.
• • A subset of participants may be enrolled in the tissue collection part of the study only (i.e. if they are too sick to travel). We can may also arrange limited remote consultation with our research team and NIH consultants, the participants referring physician and the participant/their legal guardian through the telephone or an NIH supported telehealth platform for participants who are unable to safely travel to NIH. This would not replace a study visit but would be used when travel isn t possible due to extenuating circumstances (e.g. pandemic). Participants would be encouraged to follow-up for a more thorough in-person evaluation when they are able to travel to NIH.
• • For the healthy volunteers, they will be excluded if they have halitosis, cavities, dental or gingival problems, respiratory diseases (for example, asthma or recent history of COVID19), use tobacco products (for example, cigarette smoking or chewing tobacco), or use electronic nicotine delivery systems (for example, use of e-cigarettes or vaping devices), as this may interfere with accurate measurement of their volatile organic compounds. NIH staff and their family members
• • will be eligible to participate in the healthy volunteer portion of the study.